Cell. 2023 Nov 30. pii: S0092-8674(23)01226-6. [Epub ahead of print]
Hua-Lin Zhou,
Zachary W Grimmett,
Nicholas M Venetos,
Colin T Stomberski,
Zhaoxia Qian,
Precious J McLaughlin,
Puneet K Bansal,
Rongli Zhang,
James D Reynolds,
Richard T Premont,
Jonathan S Stamler.
Acyl-coenzyme A (acyl-CoA) species are cofactors for numerous enzymes that acylate thousands of proteins. Here, we describe an enzyme that uses S-nitroso-CoA (SNO-CoA) as its cofactor to S-nitrosylate multiple proteins (SNO-CoA-assisted nitrosylase, SCAN). Separate domains in SCAN mediate SNO-CoA and substrate binding, allowing SCAN to selectively catalyze SNO transfer from SNO-CoA to SCAN to multiple protein targets, including the insulin receptor (INSR) and insulin receptor substrate 1 (IRS1). Insulin-stimulated S-nitrosylation of INSR/IRS1 by SCAN reduces insulin signaling physiologically, whereas increased SCAN activity in obesity causes INSR/IRS1 hypernitrosylation and insulin resistance. SCAN-deficient mice are thus protected from diabetes. In human skeletal muscle and adipose tissue, SCAN expression increases with body mass index and correlates with INSR S-nitrosylation. S-nitrosylation by SCAN/SNO-CoA thus defines a new enzyme class, a unique mode of receptor tyrosine kinase regulation, and a revised paradigm for NO function in physiology and disease.
Keywords: S-nitrosylation, nitric oxide, redox signaling, posttranslational modification, diabetes, nitrosylase, insulin receptor